Predicting toxicity in radiotherapy for prostate cancer

Research output: Contribution to journalArticle

Abstract

This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (

Original languageEnglish
Pages (from-to)521-532
Number of pages12
JournalPhysica Medica
Volume32
Issue number3
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

toxicity
radiation therapy
Prostatic Neoplasms
Radiotherapy
cancer
Organs at Risk
dosage
Prostatectomy
PubMed
MEDLINE
fractionation
organs
planning
Publications
Databases
optimization

Keywords

  • Acute and late toxicity
  • Dose-volume models
  • Prostate cancer
  • Radiotherapy

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging
  • Physics and Astronomy(all)

Cite this

Predicting toxicity in radiotherapy for prostate cancer. / Landoni, Valeria; Fiorino, Claudio; Cozzarini, Cesare; Sanguineti, Giuseppe; Valdagni, Riccardo; Rancati, Tiziana.

In: Physica Medica, Vol. 32, No. 3, 01.03.2016, p. 521-532.

Research output: Contribution to journalArticle

@article{a84a6fa5cd184c8d971a348380a2be87,
title = "Predicting toxicity in radiotherapy for prostate cancer",
abstract = "This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (",
keywords = "Acute and late toxicity, Dose-volume models, Prostate cancer, Radiotherapy",
author = "Valeria Landoni and Claudio Fiorino and Cesare Cozzarini and Giuseppe Sanguineti and Riccardo Valdagni and Tiziana Rancati",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.ejmp.2016.03.003",
language = "English",
volume = "32",
pages = "521--532",
journal = "Physica Medica",
issn = "1120-1797",
publisher = "Associazione Italiana di Fisica Medica",
number = "3",

}

TY - JOUR

T1 - Predicting toxicity in radiotherapy for prostate cancer

AU - Landoni, Valeria

AU - Fiorino, Claudio

AU - Cozzarini, Cesare

AU - Sanguineti, Giuseppe

AU - Valdagni, Riccardo

AU - Rancati, Tiziana

PY - 2016/3/1

Y1 - 2016/3/1

N2 - This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (

AB - This comprehensive review addresses most organs at risk involved in planning optimization for prostate cancer. It can be considered an update of a previous educational review that was published in 2009 (Fiorino et al., 2009).The literature was reviewed based on PubMed and MEDLINE database searches (from January 2009 up to September 2015), including papers in press; for each section/subsection, key title words were used and possibly combined with other more general key-words (such as radiotherapy, dose-volume effects, NTCP, DVH, and predictive model). Publications generally dealing with toxicity without any association with dose-volume effects or correlations with clinical risk factors were disregarded, being outside the aim of the review.A focus was on external beam radiotherapy, including post-prostatectomy, with conventional fractionation or moderate hypofractionation (

KW - Acute and late toxicity

KW - Dose-volume models

KW - Prostate cancer

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84963612009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963612009&partnerID=8YFLogxK

U2 - 10.1016/j.ejmp.2016.03.003

DO - 10.1016/j.ejmp.2016.03.003

M3 - Article

VL - 32

SP - 521

EP - 532

JO - Physica Medica

JF - Physica Medica

SN - 1120-1797

IS - 3

ER -